Document And Entity Information
Document And Entity Information | Mar. 10, 2023 |
Document Information [Line Items] | |
Entity, Registrant Name | NAVIDEA BIOPHARMACEUTICALS, INC. |
Document, Type | 8-K |
Document, Period End Date | Mar. 10, 2023 |
Entity, Incorporation, State or Country Code | DE |
Entity, File Number | 001-35076 |
Entity, Tax Identification Number | 31-1080091 |
Entity, Address, Address Line One | 4995 Bradenton Avenue, Suite 240 |
Entity, Address, City or Town | Dublin |
Entity, Address, State or Province | OH |
Entity, Address, Postal Zip Code | 43017 |
City Area Code | 614 |
Local Phone Number | 793-7500 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Entity, Emerging Growth Company | false |
Amendment Flag | false |
Entity, Central Index Key | 0000810509 |
CommonStock Custom [Member] | |
Document Information [Line Items] | |
Title of 12(b) Security | Common Stock |
Trading Symbol | NAVB |
Security Exchange Name | NYSE |
PreferredStockPurchaseRights Custom [Member] | |
Document Information [Line Items] | |
Title of 12(b) Security | Preferred Stock Purchase Rights |
Security Exchange Name | NYSE |
No Trading Symbol Flag | true |